DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

DaShenLin Pharmaceutical Group Market Cap

DaShenLin Pharmaceutical Group has a market cap or net worth of 19.10 billion as of November 13, 2024. Its market cap has decreased by -30.10% in one year.

• Market Cap: 19.10B
• Enterprise Value: 21.95B
• Revenue: 26.54B
• Ranking: n/a
• PE Ratio: 22.40
• Stock Price: 16.77

Market Cap Chart

Since July 31, 2017, DaShenLin Pharmaceutical Group's market cap has increased from 14.24B to 19.10B, an increase of 34.11%. That is a compound annual growth rate of 4.11%.

Market Cap History

Date	Market Cap	% Change
Nov 13, 2024	19.10B	-32.65%
Dec 29, 2023	28.36B	-24.55%
Dec 30, 2022	37.59B	12.85%
Dec 31, 2021	33.31B	-35.46%
Dec 31, 2020	51.60B	89.92%
Dec 31, 2019	27.17B	70.41%